САРКОИДОЗ: ПРЕДИКТОРЫ ЗАБОЛЕВАЕМОСТИ И РАСПРОСТРАНЕННОСТИ

В обзоре представлен анализ рандомизированных исследований, современные взгляды на проблему распространенности и заболеваемости саркоидозом. Эпидемиология саркоидоза и его клинические проявления сильно различаются по географическим регионам, различным этническим и возрастным группам, а также по полу. Проведена оценка воздействия социального статуса, профессиональных факторов, курения, сезонных вариаций. Изучены связь развития болезни с ожирением и прибавкой в весе, влияние инфекционных агентов. Проанализированы данные геномных исследований и наличие семейного саркоидоза.

саркоидоз, распространенность, заболеваемость, пол, возраст, гены, профессиональное воздействие, сезонность, курение, семейный саркоидоз

1. Диагностика и лечение саркоидоза: Федеральные согласительные клинические рекомендации. - М., 2014. - С. 1-45.

2. Саркоидоз: Клинич. рекомендации. -М., 2019. - 49 с.

3. Arkema E. V. Sarcoidosis incidence and prevalence: A nationwide register-based assessment in Sweden //Eur. Respir. J. - 2016. - V. 48, №6. - P. 1690-1699.

4. Baughman R. P. A Concise Review of Pulmonary Sarcoidosis /R. P. Baughman, D. A. Culver, M. A. Judson //Am. J. Respir. Crit. Care Med. - 2011. - V. 183, №5. - P. 573-581.

5. Baughman R. P. Sarcoidosis in America. Analysis Based on Health Care Use //Ann. Am. Thorac. Soc. - 2016. - Т. 13, №8. - P. 1244-1252.

6. Brito-Zeron P. Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences //Clin. Exp. Rheumatol. - 2016. - V. 34, №3. - P. 380-388.

7. Chen E. S. Etiologies of Sarcoidosis /E. S. Chen, D. R. Moller //Clin. Rev. Allergy Immunol. - 2015. - V. 49, №1. - P. 6-18.

8. Cozier Y. C. Obesity and Weight Gain in Relation to Incidence of Sarcoidosis in US Black Women //Chest. - 2015. - V. 147, №4. - P. 1086-1093.

9. Cozier Y. C. Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women's Health Study //Am. J. Epidemiol. - 2012. - V. 176, №7. - P. 635-641.

10. Cozier Y. C. Sarcoidosis: An Ill-afforded Disease /Y. C. Cozier, P. Govender //Am. J. Respir. Crit. Care Med. - 2020. - V. 201, №8. -P. 890-891.

11. Duchemann B. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris //Eur. Respir. J. - 2017. -V. 50, №2. - P. 160-169.

12. Dumas O. Epidemiology of Sarcoidosis in a Prospective Cohort Study of U.S. Women //Ann. Am. Thorac. Soc. - 2016. - V. 13. №1. - P. 67-71.

13. Dumas O. Prospective study of body mass index and risk of sarcoidosis in US women // Eur. Respir. J. - 2017. - V. 50, №4. - P. 170-179.

14. Durmus Kocak N. Analysis of Age Distribution and Disease Presentation of 1269 Patients with Sarcoidosis //Eurasian J. Med. - 2017. - V. 49, №3. - P. 161-166.

15. Esteves T. Is there any association between Sarcoidosis and infectious agents?: A systematic review and meta-analysis /T. Esteves, G. Aparicio, V. Garcia-Patos //BMC Pulm. - Med. -2016. - V. 16, №1. - P. 165.

16. Fidler L. M. Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study //Eur. Respir. J. -2019. - V. 54, №4. - P. 1-9.

17. Gerke A. K. An analysis of seasonality of sarcoidosis in the United States veteran population: 2000-2007 //Sarcoidosis Vasc. Diffus. Lung Dis. - 2012. - V. 29, №2. - P. 155-158.

18. Gorham E. D. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: A 27-year historical prospective study, 1975-2001 //Chest. - 2004. - V. 126, №5. - P. 1431-1438.

19. Grunewald J. HLA associations and Lofgren's syndrome //Expert Rev. Clin. Immunol. -2012. - V. 8, №1. - P. 55-62.

20. Grunewald J. Sarcoidosis //Nat. Rev. Dis. Prim. - 2019. - V. 5, №1. - P. 45.

21. Hena K. M. Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters //Chest. - 2018. - V. 153, №1. - P. 114-123.

22. Iannuzzi M. C. Genome-wide search for sarcoidosis susceptibility genes in African Americans //Genes Immun. - 2005. - V. 6, №6. - P. 509-518.

23. Jonsson E. Silica dust and sarcoidosis in Swedish construction workers /E. Jonsson, B. Jarvholm, M. Andersson //Occup. Med. (Chic. Ill). -2019. - V. 69, №7. - P. 482-486.

24. Llanos O H. N. Sarcoidosis //Med. Clin. North Am. - 2019. - V. 103, №3. - P. 527-534.

25. Mirsaeidi M. Racial Difference in Sarcoidosis Mortality in the United States //Chest. -2015. - V. 147, №2. - P. 438-449.

26. Muller-Quernheim J. Pathogenesis of sarcoidosis /J. Muller-Quernheim, A. Prasse, G. Zissel //Presse Med. - 2012. - V. 41. - P. 275-287.

27. Park J. E. Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003-2015: A nationwide population-based study //Respir. Med. -2018. - Т. 144. - P. 28-34.

28. Ramos-Casals M. How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants //Lung. - 2019. - V. 197, №4. - P. 427-436.

29. Rossman M. D. HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites //Am. J. Hum. Genet. - 2003. - V. 73, №4. - P. 720-735.

30. Roszkiewicz J. Kaleidoscope of autoimmune diseases in HIV infection /J. Roszkiewicz, E. Smolewska //Rheumatol. Int. - 2016. - V. 36, №11. - P. 1481-1491.

31. Rybicki B. A. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites //Am. J. Hum. Genet. - 2005. - Т. 77, №3. - P. 491-499.

32. Rybicki B. A. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans //Am. J. Respir. Crit. Care Med. - 2003. - V. 167, №3. - P. 444-449.

33. Salah S. Sarcoidosis //J. Fr. Ophtalmol. -2018. - V. 41, №10. - P. 451-467.

34. Sato H. HLA-DQB1*0201: A marker for good prognosis in British and Dutch patients with sarcoidosis //Am. J. Respir. Cell Mol. Biol. - 2002. -V. 27, №4. - P. 406-412.

35. Sawahata M. Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan //Respir. Med. - 2015. - V. 109, №2. - P. 272-278.

36. Soto-Gomez N. Diagnosis and Management of Sarcoidosis /N. Soto-Gomez, J. I. Peters, A. M. Nambiar //Sarcoidosis. - 2016. - V. 1. -P. 11.

37. Spagnolo P., Grunewald J. Recent advances in the genetics of sarcoidosis //J. Med. Genet. - 2013. - V. 50, №5. - P. 290-297.

38. Suzuki H. Genetic Characterization and Susceptibility for Sarcoidosis in Japanese Patients: Risk Factors of BTNL2 Gene Polymorphisms and HLA Class II Alleles //Investig. Opthalmology Vis. Sci. - 2012. - V. 53, №11. - P. 7109.

39. Terwiel M. Clinical epidemiology of familial sarcoidosis: A systematic literature review /M. Terwiel, C. H. M. Moorsel //Respir. Med. - 2019. -V. 149. - P. 36-41.

40. Tussupbekova M. M. Diagnostic difficulties of lungs sarcoidosis /M. M. Tussupbekova, R. A. Bakenova, L. M. Stabayeva //Вестник КазН-МУ. - 2019. - №1. - P. 284-288.

41. Ungprasert P. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis /P. Ungprasert, J. H. Ryu, E. L. Matteson //Mayo Clin. Proc. Innov. Qual. Outcomes. - 2019. - V. 3, №3. - P. 358-375.

42. Ungprasert P. Epidemiology and clinical characteristics of sarcoidosis: An update from a population-based cohort study from olmsted county, minnesota /P. Ungprasert, C. S. Crowson, E. L. Matteson //Reumatismo. - 2017. - V. 69, №1. - P. 16-22.

43. Ungprasert P. Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976-2013 /P. Ungprasert, C. S. Crowson, E. L. Matteson //Lung. - 2017. - V. 195, №1. - P. 87-91.

44. Ungprasert P. Seasonal variation in incidence of sarcoidosis: A population-based study, 1976-2013 /P. Ungprasert, C. S. Crowson, E. L. Matteson //Thorax. - 2016. - V. 71, №12. -P. 1164-1166.

45. Ungprasert P. Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study /P. Ungprasert, C. S. Crowson, E. L. Matteson // Respir. Med. - 2016. - V. 120. - P. 87-90.

46. Valeyre D. Sarcoidosis //Lancet. -2014. - V. 383, №9923. - С. 1155-1167.

47. Vizel A. A. Epidemiology of Sarcoidosis in the Russian Federation /A. A. Vizel, I. Y. Vizel, N. B. Amirov //Bull. Contemp. Clin. Med. - 2017. -V. 10, №5. - P. 66-73.

48. Webber M. P. Post-9/11 sarcoidosis in WTC-exposed firefighters and emergency medical service workers //Int. J. Environ. Res. Public Health. - 2019. - V. 16 (10). - P. 1727.

49. Wilsher M. L. Characteristics of sarcoidosis in Maori and Pacific Islanders // Respirology. - 2017. - V. 22, №2. - P. 360-363.

50. Wu C.-H. Comorbid autoimmune diseases in patients with sarcoidosis: A nationwide case-control study in Taiwan //J. Dermatol. -2017. - V. 44, №4. - P. 423-430.